Knowledge portal for inclusion of children in clinical trials
Introduction
The principle that children are not small adults remains the foundation for this resource: medicines developed for adults cannot simply be extrapolated to children because of well-recognized physiological, developmental and pharmacological differences between children and adults. For decades, studies of new drugs involving infants, children and adolescents have often been delayed relative to adults or never performed, resulting in a significant evidence gap that has left many effective treatments unlicensed or used off-label in paediatric practice.
Closing this gap matters beyond childhood itself. A life-course approach recognizes that health in childhood shapes health in adulthood and that clinical development of children’s medicines is therefore an investment in the trajectory of a whole life. The development of medicine for children and adults should be seen as a continuum rather than as separate pathways. Connecting the two through streamlined, coordinated approaches, such as earlier and better-aligned paediatric planning, shared evidence generation and harmonized regulatory and study design, can reduce delays and duplication and ensure that safe, effective, age-appropriate treatments reach children when they need them and carry through into adult care.
In May 2022, the World Health Assembly adopted resolution WHA75.8 to promote collaboration and equity in clinical trial practices by standardizing the inclusion of underrepresented populations, including children, to enhance their health outcomes and well-being. The inaugural WHO Global Clinical Trials Forum in November 2023 highlighted the urgency of including underrepresented groups in clinical research. In response to resolution WHA75.8, WHO published Guidance for best practices for clinical trials in 2024 and then a research agenda in 2025 to strengthen paediatric clinical trials and set research priorities to close critical gaps in research on child health (Box 1).
| Box 1. Critical gaps in paediatric research |
|---|
|
| Source: The future of paediatric clinical trials – setting research priorities for child health: technical report. Geneva: World Health Organization; 2025 (iris.who.int/handle/10665/383291). Licence: CC BY-NC-SA 3.0 IGO. |
The information in this knowledge portal was developed to address these gaps by providing practical guidance to support the design, implementation and oversight of clinical trials involving neonates, children and young people. It is intended as a living resource that draws on the latest international guidelines, regulatory frameworks and research literature and that will be updated as the field evolves.